Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Asset Utilization Ratio (2023 - 2025)

Historic Asset Utilization Ratio for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to 0.82.

  • Indivior Pharmaceuticals' Asset Utilization Ratio rose 430.25% to 0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82, marking a year-over-year increase of 430.25%. This contributed to the annual value of 0.77 for FY2024, which is 2470.9% up from last year.
  • Indivior Pharmaceuticals' Asset Utilization Ratio amounted to 0.82 in Q3 2025, which was up 430.25% from 0.83 recorded in Q2 2025.
  • Over the past 5 years, Indivior Pharmaceuticals' Asset Utilization Ratio peaked at 0.87 during Q1 2025, and registered a low of 0.53 during Q1 2023.
  • Over the past 3 years, Indivior Pharmaceuticals' median Asset Utilization Ratio value was 0.77 (recorded in 2024), while the average stood at 0.72.
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Asset Utilization Ratio skyrocketed by 4114.28% in 2024, and later surged by 430.25% in 2025.
  • Over the past 3 years, Indivior Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.61 in 2023, then skyrocketed by 41.14% to 0.85 in 2024, then decreased by 3.72% to 0.82 in 2025.
  • Its Asset Utilization Ratio was 0.82 in Q3 2025, compared to 0.83 in Q2 2025 and 0.87 in Q1 2025.